Your browser doesn't support javascript.
loading
Diethyldithiocarbamate copper nanoparticle overcomes resistance in cancer therapy without inhibiting P-glycoprotein.
Kang, Xuejia; Wang, Junwei; Huang, Chung-Hui; Wibowo, Fajar Setyo; Amin, Rajesh; Chen, Pengyu; Li, Feng.
Afiliación
  • Kang X; Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL 36849, USA; Materials Research and Education Center, Materials Engineering, Department of Mechanical Engineering, Auburn University, Auburn, AL 36849, USA.
  • Wang J; Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL 36849, USA.
  • Huang CH; Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL 36849, USA.
  • Wibowo FS; Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL 36849, USA.
  • Amin R; Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL 36849, USA.
  • Chen P; Materials Research and Education Center, Materials Engineering, Department of Mechanical Engineering, Auburn University, Auburn, AL 36849, USA.
  • Li F; Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL 36849, USA; National Institute on Drug Abuse, National Institutes of Health, North Bethesda, MD 20852, USA. Electronic address: lif10@nih.gov.
Nanomedicine ; 47: 102620, 2023 01.
Article en En | MEDLINE | ID: mdl-36265559

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ditiocarba / Resistencia a Antineoplásicos / Neoplasias Límite: Animals / Humans Idioma: En Revista: Nanomedicine Asunto de la revista: BIOTECNOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ditiocarba / Resistencia a Antineoplásicos / Neoplasias Límite: Animals / Humans Idioma: En Revista: Nanomedicine Asunto de la revista: BIOTECNOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos